GB8514090D0
(en)
*
|
1985-06-04 |
1985-07-10 |
Sandoz Ltd |
Organic compounds
|
JPS61267528A
(ja)
*
|
1984-11-26 |
1986-11-27 |
Yamanouchi Pharmaceut Co Ltd |
吸収促進剤を含有するカルシトニン経鼻剤
|
JPS61137828A
(ja)
*
|
1984-12-07 |
1986-06-25 |
Shionogi & Co Ltd |
γ−インタ−フエロン製剤組成物
|
JPS61194034A
(ja)
*
|
1985-02-25 |
1986-08-28 |
Teijin Ltd |
経鼻投与用粉末状組成物
|
US5643565A
(en)
*
|
1985-09-20 |
1997-07-01 |
Chiron Corporation |
Human IL-2 as a vaccine adjuvant
|
US5503841A
(en)
*
|
1985-09-20 |
1996-04-02 |
Cetus Oncology Corporation |
Human IL-2 as a vaccine adjuvant
|
DE3601923A1
(de)
*
|
1986-01-23 |
1987-07-30 |
Behringwerke Ag |
Nasal applizierbares arzneimittel, verfahren zu seiner herstellung und seine verwendung
|
US4734401A
(en)
*
|
1986-03-17 |
1988-03-29 |
W. R. Grace & Co. |
Process for spray drying amino acid compositions
|
DK179286D0
(da)
*
|
1986-04-18 |
1986-04-18 |
Nordisk Gentofte |
Insulinpraeparat
|
CA1291036C
(en)
*
|
1986-04-23 |
1991-10-22 |
Edwin I. Stoltz |
Nasal administration of drugs
|
CA1257199A
(en)
*
|
1986-05-20 |
1989-07-11 |
Paul Y. Wang |
Preparation containing bioactive macromolecular substance for multi-months release in vivo
|
US4962091A
(en)
*
|
1986-05-23 |
1990-10-09 |
Syntex (U.S.A.) Inc. |
Controlled release of macromolecular polypeptides
|
HU198626B
(en)
*
|
1986-05-27 |
1989-11-28 |
Sandoz Ag |
Process for producing pharmaceutical compositions comprising somatostatin analogues as active ingredient
|
IT1204400B
(it)
*
|
1986-06-20 |
1989-03-01 |
Sclavo Spa |
Composizioni farmaceutiche contenente una calcitonina
|
CH671155A5
(de)
*
|
1986-08-18 |
1989-08-15 |
Clinical Technologies Ass |
|
DE3726517A1
(de)
*
|
1986-08-18 |
1988-03-03 |
Sandoz Ag |
Nasale zusammensetzungen, welche octreotid enthalten
|
USRE35862E
(en)
*
|
1986-08-18 |
1998-07-28 |
Emisphere Technologies, Inc. |
Delivery systems for pharmacological agents encapsulated with proteinoids
|
ATE76311T1
(de)
|
1986-08-19 |
1992-06-15 |
Genentech Inc |
Einrichtung und dispersion zum intrapulmonalen eingeben von polypeptidwuchsstoffen und zytokinen.
|
US5811128A
(en)
*
|
1986-10-24 |
1998-09-22 |
Southern Research Institute |
Method for oral or rectal delivery of microencapsulated vaccines and compositions therefor
|
US5075109A
(en)
*
|
1986-10-24 |
1991-12-24 |
Southern Research Institute |
Method of potentiating an immune response
|
JPH0688898B2
(ja)
*
|
1986-10-31 |
1994-11-09 |
帝人株式会社 |
アスコルビン酸類を含有する経鼻投与用粉末状組成物
|
JP2505430B2
(ja)
*
|
1986-11-04 |
1996-06-12 |
帝人株式会社 |
塩基性アミノ酸を含有する経鼻投与用粉末状組成物
|
EP0300036A4
(de)
*
|
1987-01-30 |
1989-06-14 |
Biomed Res Consultants Ltd |
Auf vasopressin basierte arzneimittelzubereitungen.
|
US5690954A
(en)
*
|
1987-05-22 |
1997-11-25 |
Danbiosyst Uk Limited |
Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
|
GB8712176D0
(en)
*
|
1987-05-22 |
1987-06-24 |
Cosmas Damian Ltd |
Drug delivery system
|
IT1222395B
(it)
*
|
1987-07-30 |
1990-09-05 |
Pierrel Spa |
Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
|
US5059587A
(en)
*
|
1987-08-03 |
1991-10-22 |
Toyo Jozo Company, Ltd. |
Physiologically active peptide composition for nasal administration
|
DE3726324A1
(de)
*
|
1987-08-07 |
1989-02-16 |
Hoechst Ag |
Cyclopeptide als resorptionsfoerderer bei applikation auf die schleimhaeute
|
PT88490B
(pt)
*
|
1987-09-14 |
1992-11-30 |
Novo Nordisk As |
Processo para a preparacao de composicoes farmaceuticas para libertacao nao-enterica trans-mucosa contendo monossacaridos ou oligossacaridos
|
IT1222734B
(it)
*
|
1987-09-25 |
1990-09-12 |
Scalvo S P A |
Formulaziopne farmaceutiche e forme di dosaggio per la somminaistarzione rettale di calcitonina
|
GB8723846D0
(en)
*
|
1987-10-10 |
1987-11-11 |
Danbiosyst Ltd |
Bioadhesive microsphere drug delivery system
|
JP2851627B2
(ja)
*
|
1987-10-15 |
1999-01-27 |
シンテックス(ユー・エス・エイ)インコーポレイテッド |
粉末形態ポリプペチド類の経鼻投与
|
GB2212062B
(en)
*
|
1987-11-13 |
1991-07-17 |
Isf Spa |
Pharmaceutical compositions containing a calcitonin and a glycyrrhizinate ab- sorption enhancer
|
FR2634376B1
(fr)
*
|
1988-07-21 |
1992-04-17 |
Farmalyoc |
Nouvelle forme unitaire, solide et poreuse comprenant des microparticules et/ou des nanoparticules, ainsi que sa preparation
|
JPH02104531A
(ja)
*
|
1988-10-14 |
1990-04-17 |
Toyo Jozo Co Ltd |
経鼻投与用生理活性ペプチド組成物
|
EP0396777A4
(en)
*
|
1988-11-14 |
1991-03-13 |
Otsuka Pharmaceutical Co., Ltd. |
Interferon preparation for nasal administration
|
US5567682A
(en)
*
|
1988-12-16 |
1996-10-22 |
Advanced Peptides And Biotechnology Sciences |
Method of treating Alzheimer's disease
|
JP2704546B2
(ja)
*
|
1989-04-04 |
1998-01-26 |
光利 太良 |
Atll治療用吸入剤
|
IT8920486A0
(it)
*
|
1989-05-12 |
1989-05-12 |
Isf Spa |
Composizioni farmaceutiche.
|
GB2237510B
(en)
*
|
1989-11-04 |
1993-09-15 |
Danbiosyst Uk |
Small particle drug compositions for nasal administration
|
US5707644A
(en)
*
|
1989-11-04 |
1998-01-13 |
Danbiosyst Uk Limited |
Small particle compositions for intranasal drug delivery
|
US5175146A
(en)
*
|
1989-12-05 |
1992-12-29 |
Vical, Inc. |
Synthetic calcitonin peptides
|
US5364840A
(en)
*
|
1989-12-05 |
1994-11-15 |
Vical, Inc. |
Synthetic calcitonin peptides
|
US5624898A
(en)
*
|
1989-12-05 |
1997-04-29 |
Ramsey Foundation |
Method for administering neurologic agents to the brain
|
US6407061B1
(en)
*
|
1989-12-05 |
2002-06-18 |
Chiron Corporation |
Method for administering insulin-like growth factor to the brain
|
US5188825A
(en)
*
|
1989-12-28 |
1993-02-23 |
Iles Martin C |
Freeze-dried dosage forms and methods for preparing the same
|
US5376386A
(en)
*
|
1990-01-24 |
1994-12-27 |
British Technology Group Limited |
Aerosol carriers
|
GB9001635D0
(en)
*
|
1990-01-24 |
1990-03-21 |
Ganderton David |
Aerosol carriers
|
JPH05963A
(ja)
*
|
1990-04-13 |
1993-01-08 |
Toray Ind Inc |
ポリペプチド類組成物
|
EP0532546B1
(de)
*
|
1990-05-10 |
1998-03-18 |
Bechgaard International Research And Development A/S |
Pharmazeutische zubereitung enthaltend n-glykofurole und n-äthylenglykole
|
EP0462305B1
(de)
*
|
1990-06-21 |
1994-11-02 |
Huland, Edith, Dr. Dr. |
Verwendung zytokinhaltiger Aerosole und zytokinhaltige Aerosole selbst
|
US5780012A
(en)
*
|
1990-06-21 |
1998-07-14 |
Huland; Edith |
Method for reducing lung afflictions by inhalation of cytokine solutions
|
US5541155A
(en)
*
|
1994-04-22 |
1996-07-30 |
Emisphere Technologies, Inc. |
Acids and acid salts and their use in delivery systems
|
US6099856A
(en)
*
|
1992-06-15 |
2000-08-08 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5714167A
(en)
*
|
1992-06-15 |
1998-02-03 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5578323A
(en)
*
|
1992-06-15 |
1996-11-26 |
Emisphere Technologies, Inc. |
Proteinoid carriers and methods for preparation and use thereof
|
US6221367B1
(en)
|
1992-06-15 |
2001-04-24 |
Emisphere Technologies, Inc. |
Active agent transport systems
|
US5443841A
(en)
*
|
1992-06-15 |
1995-08-22 |
Emisphere Technologies, Inc. |
Proteinoid microspheres and methods for preparation and use thereof
|
US5629020A
(en)
*
|
1994-04-22 |
1997-05-13 |
Emisphere Technologies, Inc. |
Modified amino acids for drug delivery
|
US5693338A
(en)
*
|
1994-09-29 |
1997-12-02 |
Emisphere Technologies, Inc. |
Diketopiperazine-based delivery systems
|
US5447728A
(en)
*
|
1992-06-15 |
1995-09-05 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US6344213B1
(en)
|
1996-03-29 |
2002-02-05 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6331318B1
(en)
*
|
1994-09-30 |
2001-12-18 |
Emisphere Technologies Inc. |
Carbon-substituted diketopiperazine delivery systems
|
IL99699A
(en)
*
|
1990-10-10 |
2002-04-21 |
Autoimmune Inc |
Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
|
GB9101592D0
(en)
*
|
1991-01-24 |
1991-03-06 |
Glaxo Group Ltd |
Compositions
|
DK49791D0
(da)
*
|
1991-03-20 |
1991-03-20 |
Novo Nordisk As |
Nasalt pulverpraeparat
|
IT1247472B
(it)
*
|
1991-05-31 |
1994-12-17 |
Fidia Spa |
Processo per la preparazione di microsfere contenenti componenti biologicamente attivi.
|
DE4222647A1
(de)
*
|
1991-07-15 |
1993-01-21 |
Sandoz Ag |
Peptid-zubereitungen
|
AU2348492A
(en)
*
|
1991-07-19 |
1993-02-23 |
East Carolina University |
Method of treating asthma
|
RU2054180C1
(ru)
*
|
1991-08-21 |
1996-02-10 |
Жирнов Олег Петрович (н/п) |
Способ лечения вирусных респираторных инфекций
|
US5792451A
(en)
*
|
1994-03-02 |
1998-08-11 |
Emisphere Technologies, Inc. |
Oral drug delivery compositions and methods
|
US5811127A
(en)
*
|
1992-06-15 |
1998-09-22 |
Emisphere Technologies, Inc. |
Desferrioxamine oral delivery system
|
US6582728B1
(en)
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
DE69332105T2
(de)
|
1992-09-29 |
2003-03-06 |
Inhale Therapeutic Systems San |
Pulmonale abgabe von aktiven fragmenten des parathormons
|
US5401516A
(en)
*
|
1992-12-21 |
1995-03-28 |
Emisphere Technologies, Inc. |
Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof
|
US5354934A
(en)
†
|
1993-02-04 |
1994-10-11 |
Amgen Inc. |
Pulmonary administration of erythropoietin
|
US5981719A
(en)
*
|
1993-03-09 |
1999-11-09 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
US6090925A
(en)
*
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
CA2158040A1
(en)
*
|
1993-03-11 |
1994-09-15 |
Jacqueline D. Duncan |
Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces
|
EP1025840B1
(de)
*
|
1993-04-22 |
2005-06-29 |
Emisphere Technologies, Inc. |
Orale Dareichungsform
|
US5958457A
(en)
*
|
1993-04-22 |
1999-09-28 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5709861A
(en)
*
|
1993-04-22 |
1998-01-20 |
Emisphere Technologies, Inc. |
Compositions for the delivery of antigens
|
US5643957A
(en)
*
|
1993-04-22 |
1997-07-01 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6632456B1
(en)
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
TW402506B
(en)
*
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
SE9303574D0
(sv)
*
|
1993-11-01 |
1993-11-01 |
Kabi Pharmacia Ab |
Composition for drug delivery and method the manufacturing thereof
|
US6051256A
(en)
|
1994-03-07 |
2000-04-18 |
Inhale Therapeutic Systems |
Dispersible macromolecule compositions and methods for their preparation and use
|
MX9603936A
(es)
|
1994-03-07 |
1997-05-31 |
Inhale Therapeutic Syst |
Metodos y composiciones para el suministro pulmonar de insulina.
|
AU696387B2
(en)
|
1994-05-18 |
1998-09-10 |
Inhale Therapeutic Systems, Inc. |
Methods and compositions for the dry powder formulation of interferons
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US6290991B1
(en)
*
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
SE9404468D0
(sv)
*
|
1994-12-22 |
1994-12-22 |
Astra Ab |
Powder formulations
|
EP0806945B1
(de)
*
|
1994-12-22 |
2003-04-23 |
AstraZeneca AB |
Parathyroidhormon pth enthaltende therapeutische zubereitung zur inhalation
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
CN1088580C
(zh)
|
1994-12-22 |
2002-08-07 |
阿斯特拉公司 |
气溶胶药物制剂
|
DE726075T1
(de)
*
|
1995-02-08 |
1996-12-12 |
Therapicon Srl |
Nicht-inorganische pharmazeutische salzige Lösungen zur endonasale Verabreichung
|
US5965121A
(en)
*
|
1995-03-31 |
1999-10-12 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5866536A
(en)
*
|
1995-03-31 |
1999-02-02 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5650386A
(en)
*
|
1995-03-31 |
1997-07-22 |
Emisphere Technologies, Inc. |
Compositions for oral delivery of active agents
|
BR9604880A
(pt)
*
|
1995-03-31 |
1998-05-19 |
Emisphere Tech Inc |
Composto composição forma de unidade de dosagem métodos para administração de um agente biologicamente ativo para preparar uma composição para administração de um agente ativo e para preparar um composto e composição farmacológica
|
US6090958A
(en)
*
|
1995-03-31 |
2000-07-18 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5989539A
(en)
*
|
1995-03-31 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6001347A
(en)
|
1995-03-31 |
1999-12-14 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5820881A
(en)
*
|
1995-04-28 |
1998-10-13 |
Emisphere Technologies, Inc. |
Microspheres of diamide-dicarboxylic acids
|
US6428771B1
(en)
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
US6051258A
(en)
*
|
1995-06-07 |
2000-04-18 |
Emisphere Technologies, Inc. |
Proteinoid emulsions and methods for preparation and use thereof
|
US5750147A
(en)
|
1995-06-07 |
1998-05-12 |
Emisphere Technologies, Inc. |
Method of solubilizing and encapsulating itraconazole
|
US5667806A
(en)
*
|
1995-06-07 |
1997-09-16 |
Emisphere Technologies, Inc. |
Spray drying method and apparatus
|
US5824345A
(en)
*
|
1995-06-07 |
1998-10-20 |
Emisphere Technologies, Inc. |
Fragrances and flavorants
|
JP3098401B2
(ja)
*
|
1995-07-12 |
2000-10-16 |
株式会社エルティーティー研究所 |
経鼻投与用製剤
|
GB2320248B
(en)
*
|
1995-09-11 |
1999-04-14 |
Emisphere Tech Inc |
Method for preparing omega-aminoalkanoic acid derivatives from cycloalkanones
|
JP3263598B2
(ja)
*
|
1995-11-01 |
2002-03-04 |
有限会社ドット |
経鼻吸収用生理活性ペプチド組成物
|
US6270795B1
(en)
|
1995-11-09 |
2001-08-07 |
Microbiological Research Authority |
Method of making microencapsulated DNA for vaccination and gene therapy
|
DK0943326T4
(da)
|
1996-02-27 |
2007-01-22 |
Teijin Ltd |
Pulveragtigt præparat til nasal administration
|
EP0904065A4
(de)
|
1996-06-14 |
2000-06-14 |
Emisphere Tech Inc |
Mikroverkapselte duftstoffe und herstellungsverfahren
|
JP3020141B2
(ja)
*
|
1996-10-07 |
2000-03-15 |
株式会社富士薬品 |
経鼻投与用製剤
|
US5968895A
(en)
*
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
US6358504B1
(en)
|
1997-02-07 |
2002-03-19 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6313088B1
(en)
|
1997-02-07 |
2001-11-06 |
Emisphere Technologies, Inc. |
8-[(2-hydroxy-4-methoxy benzoyl) amino]-octanoic acid compositions for delivering active agents
|
US5939381A
(en)
*
|
1997-02-07 |
1999-08-17 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5990166A
(en)
*
|
1997-02-07 |
1999-11-23 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5876710A
(en)
*
|
1997-02-07 |
1999-03-02 |
Emisphere Technologies Inc. |
Compounds and compositions for delivering active agents
|
US5879681A
(en)
*
|
1997-02-07 |
1999-03-09 |
Emisphere Technolgies Inc. |
Compounds and compositions for delivering active agents
|
US5804688A
(en)
*
|
1997-02-07 |
1998-09-08 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US6060513A
(en)
*
|
1997-02-07 |
2000-05-09 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
GB9707934D0
(en)
*
|
1997-04-18 |
1997-06-04 |
Danbiosyst Uk |
Improved delivery of drugs to mucosal surfaces
|
US5863944A
(en)
*
|
1997-04-30 |
1999-01-26 |
Emisphere Technologies, Inc. |
Compounds and compositions for delivering active agents
|
US5962710A
(en)
*
|
1997-05-09 |
1999-10-05 |
Emisphere Technologies, Inc. |
Method of preparing salicyloylamino acids
|
US8765177B2
(en)
*
|
1997-09-12 |
2014-07-01 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US7153845B2
(en)
*
|
1998-08-25 |
2006-12-26 |
Columbia Laboratories, Inc. |
Bioadhesive progressive hydration tablets
|
US6309623B1
(en)
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US6565885B1
(en)
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
TWI243687B
(en)
|
1998-04-21 |
2005-11-21 |
Teijin Ltd |
Pharmaceutical composition for application to mucosa
|
US6190699B1
(en)
*
|
1998-05-08 |
2001-02-20 |
Nzl Corporation |
Method of incorporating proteins or peptides into a matrix and administration thereof through mucosa
|
US7022683B1
(en)
|
1998-05-13 |
2006-04-04 |
Carrington Laboratories, Inc. |
Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
|
DE19826628C1
(de)
*
|
1998-06-17 |
2000-07-20 |
Werner Kern |
Intranasale Verwendung von Insulin bei Hirnleistungsstörungen
|
SK262001A3
(en)
*
|
1998-07-08 |
2001-09-11 |
Kirin Amgen Inc |
Powdery preparation for mucosal administration containing polymeric medicine
|
ES2263282T3
(es)
*
|
1998-08-26 |
2006-12-01 |
Teijin Limited |
Composiciones en polvo para administracion nasal.
|
US7273618B2
(en)
*
|
1998-12-09 |
2007-09-25 |
Chiron Corporation |
Method for administering agents to the central nervous system
|
RU2140285C1
(ru)
*
|
1999-01-25 |
1999-10-27 |
Гапонюк Петр Яковлевич |
Противовирусное средство - капли в нос "гриппферон"
|
US6258857B1
(en)
*
|
1999-02-04 |
2001-07-10 |
Kyowa Industrial Co., Ltd. |
Internal liquid composition contained as internal liquid in a releasing container and releasing container product
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
AU779986B2
(en)
|
1999-06-29 |
2005-02-24 |
Mannkind Corporation |
Purification and stabilization of peptide and protein pharmaceutical agents
|
US7678087B2
(en)
*
|
1999-09-29 |
2010-03-16 |
Heska Corporation |
Equine intranasal delivery system
|
US6398774B1
(en)
|
1999-09-29 |
2002-06-04 |
Heska Corporation |
Intranasal delivery system
|
AR026073A1
(es)
|
1999-10-20 |
2002-12-26 |
Nycomed Gmbh |
Composicion farmaceutica acuosa que contiene ciclesonida
|
DE60103504T2
(de)
*
|
2000-01-20 |
2005-06-09 |
Basilea Pharmaceutica Ag |
Nasal verabreichbare cyclische antimykotische peptidzusammensetzungen
|
US20030118598A1
(en)
*
|
2000-02-08 |
2003-06-26 |
Allergan, Inc. |
Clostridial toxin pharmaceutical compositions
|
US8632785B2
(en)
*
|
2000-02-08 |
2014-01-21 |
Allergan, Inc. |
Clostridial toxin pharmaceutical composition containing a gelatin fragment
|
US20060269575A1
(en)
*
|
2000-02-08 |
2006-11-30 |
Allergan, Inc. |
Botulinum toxin pharmaceutical compositions formulated with recombinant albumin
|
EP1586329A1
(de)
*
|
2000-02-08 |
2005-10-19 |
Allergan, Inc. |
Pharmazeutische Zusammensetzungen mit botulinum Toxin
|
US7780967B2
(en)
|
2000-02-08 |
2010-08-24 |
Allergan, Inc. |
Reduced toxicity Clostridial toxin pharmaceutical compositions
|
US20030138460A1
(en)
*
|
2000-02-08 |
2003-07-24 |
Allergan, Inc |
Methods of treating animals with botulinum toxin pharmaceutical compositions
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
US7871598B1
(en)
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
AU6124601A
(en)
|
2000-05-10 |
2001-11-20 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
GB0011807D0
(en)
*
|
2000-05-16 |
2000-07-05 |
Quadrant Holdings Cambridge |
Formulation for inhalation
|
US7575761B2
(en)
|
2000-06-30 |
2009-08-18 |
Novartis Pharma Ag |
Spray drying process control of drying kinetics
|
WO2002032564A1
(fr)
*
|
2000-10-13 |
2002-04-25 |
National Institute Of Advanced Industrial Science And Technology |
Procede et appareil de production de liposomes
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
US7494669B2
(en)
|
2001-02-28 |
2009-02-24 |
Carrington Laboratories, Inc. |
Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
|
US6777000B2
(en)
|
2001-02-28 |
2004-08-17 |
Carrington Laboratories, Inc. |
In-situ gel formation of pectin
|
US7244703B2
(en)
*
|
2001-06-22 |
2007-07-17 |
Bentley Pharmaceuticals, Inc. |
Pharmaceutical compositions and methods for peptide treatment
|
CA2433583A1
(en)
*
|
2001-07-05 |
2003-01-16 |
Translational Research Ltd. |
Composition of insulin for nasal administration
|
AU2002366267B2
(en)
*
|
2001-11-19 |
2007-05-10 |
Becton, Dickinson And Company |
Pharmaceutical compositions in particulate form
|
JP2005514393A
(ja)
|
2001-12-19 |
2005-05-19 |
ネクター セラピューティクス |
アミノグリコシドの肺への供給
|
US7666876B2
(en)
*
|
2002-03-19 |
2010-02-23 |
Vernalis (R&D) Limited |
Buprenorphine formulations for intranasal delivery
|
ES2300568T3
(es)
|
2002-03-20 |
2008-06-16 |
Mannkind Corporation |
Aparato de inhalacion.
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
WO2003097080A1
(en)
*
|
2002-05-15 |
2003-11-27 |
Sun Pharmaceutical Industries Limited |
A stable aqueous composition of a peptide
|
US20090035260A1
(en)
*
|
2002-07-29 |
2009-02-05 |
Therapicon Srl |
Enhanced nasal composition of active peptide
|
GB0300531D0
(en)
|
2003-01-10 |
2003-02-12 |
West Pharm Serv Drug Res Ltd |
Pharmaceutical compositions
|
WO2004073729A1
(ja)
*
|
2003-02-21 |
2004-09-02 |
Translational Research Ltd. |
薬物の経鼻投与用組成物
|
AU2003220808B2
(en)
|
2003-03-27 |
2008-08-21 |
Bioactis Limited |
Powder medicine applicator for nasal cavity
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
BRPI0418589A
(pt)
*
|
2003-12-08 |
2008-01-29 |
Bentley Pharmaceuticals Inc |
composições farmacêuticas e métodos para tratamento por insulina
|
ITMI20040235A1
(it)
*
|
2004-02-13 |
2004-05-13 |
Therapicon Srl |
Preparazione farmaceutica per il cavo orale
|
US20080090753A1
(en)
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
US8673360B2
(en)
|
2004-08-10 |
2014-03-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Compositions that enable rapid-acting and highly absorptive intranasal administration
|
MX2007001903A
(es)
|
2004-08-20 |
2007-08-02 |
Mannkind Corp |
Catalisis de sintesis de dicetopiperazina.
|
KR101306384B1
(ko)
|
2004-08-23 |
2013-09-09 |
맨카인드 코포레이션 |
약물 전달용 디케토피페라진염, 디케토모르포린염 또는디케토디옥산염
|
US7115561B2
(en)
*
|
2004-09-22 |
2006-10-03 |
Patterson James A |
Medicament composition and method of administration
|
GB2420707A
(en)
*
|
2004-10-11 |
2006-06-07 |
Nasaleze Patents Ltd |
Compositions for intranasal administration
|
JP5465878B2
(ja)
|
2005-09-14 |
2014-04-09 |
マンカインド コーポレイション |
活性薬剤に対する結晶性微粒子表面の親和性を増大させることに基づく薬物処方の方法
|
US8084420B2
(en)
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
CN104383546B
(zh)
|
2006-02-22 |
2021-03-02 |
曼金德公司 |
用于改善包含二酮哌嗪和活性剂的微粒的药物性质的方法
|
ES2652415T3
(es)
|
2006-12-26 |
2018-02-02 |
Shin Nippon Biomedical Laboratories, Ltd. |
Preparación para aplicación transnasal
|
CN104689432B
(zh)
|
2008-06-13 |
2018-07-06 |
曼金德公司 |
干粉吸入器和用于药物输送的系统
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
JP5479465B2
(ja)
|
2008-06-20 |
2014-04-23 |
マンカインド コーポレイション |
吸入努力をリアルタイムにプロファイルする対話式機器および方法
|
TWI494123B
(zh)
|
2008-08-11 |
2015-08-01 |
Mannkind Corp |
超快起作用胰島素之用途
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
PL2405963T3
(pl)
|
2009-03-11 |
2014-04-30 |
Mannkind Corp |
Urządzenie, układ i sposób pomiaru oporu inhalatora
|
WO2010131486A1
(en)
|
2009-05-15 |
2010-11-18 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal pharmaceutical compositions with improved pharmacokinetics
|
EP2440184B1
(de)
|
2009-06-12 |
2023-04-05 |
MannKind Corporation |
Diketopiperazin-mikropartikel mit definierten spefiischen oberflächenbereichen
|
GB2472327B
(en)
|
2009-07-31 |
2013-03-13 |
Shin Nippon Biomedical Lab Ltd |
Intranasal granisetron and nasal applicator
|
WO2011056889A1
(en)
|
2009-11-03 |
2011-05-12 |
Mannkind Corporation |
An apparatus and method for simulating inhalation efforts
|
RU2571331C1
(ru)
|
2010-06-21 |
2015-12-20 |
Маннкайнд Корпорейшн |
Системы и способы доставки сухих порошковых лекарств
|
MX350838B
(es)
|
2011-02-11 |
2017-09-18 |
Grain Proc Corporation * |
Composicion de sal.
|
DK2694402T3
(en)
|
2011-04-01 |
2017-07-03 |
Mannkind Corp |
BLISTER PACKAGE FOR PHARMACEUTICAL CYLINDER AMPULS
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
AU2012328885B2
(en)
|
2011-10-24 |
2017-08-31 |
Mannkind Corporation |
Methods and compositions for treating pain
|
US9789071B2
(en)
|
2012-06-27 |
2017-10-17 |
G2B Pharma, Inc. |
Intranasal formulation of epinephrine for the treatment of anaphylaxis
|
AU2013289957B2
(en)
|
2012-07-12 |
2017-02-23 |
Mannkind Corporation |
Dry powder drug delivery systems and methods
|
WO2014066856A1
(en)
|
2012-10-26 |
2014-05-01 |
Mannkind Corporation |
Inhalable influenza vaccine compositions and methods
|
WO2014137877A1
(en)
|
2013-03-04 |
2014-09-12 |
Besins Healthcare Luxembourg Sarl |
Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles
|
EP3587404B1
(de)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Mikrokristalline diketopiperazinzusammensetzungen, verfahren zur herstellung und deren verwendung
|
BR112016000937A8
(pt)
|
2013-07-18 |
2021-06-22 |
Mannkind Corp |
formulações farmacêuticas de pó seco, método para a fabricação de uma formulação de pó seco e uso de uma formulação farmacêutica de pó seco
|
JP2016530930A
(ja)
|
2013-08-05 |
2016-10-06 |
マンカインド コーポレイション |
通気装置及び方法
|
JP2016531140A
(ja)
*
|
2013-09-03 |
2016-10-06 |
ジー2ビー ファーマ インコーポレーテッド |
心肺機能蘇生(cpr)、心臓の生命維持(cls)、アナフィラキシー及び/又はアナフィラクトイド反応の治療のための経鼻投与製剤
|
DK3049059T3
(da)
*
|
2013-09-24 |
2022-01-31 |
Satsuma Pharmaceuticals Inc |
Intranasal dhe formulering til behandlingen af hovedpine
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
PT3242676T
(pt)
|
2015-01-07 |
2023-12-06 |
TONIX Pharmaceuticals Holding Corp |
Formulações de ocitocina que contém magnésio e métodos de uso
|
US11744967B2
(en)
|
2017-09-26 |
2023-09-05 |
Shin Nippon Biomedical Laboratories, Ltd. |
Intranasal delivery devices
|
CN113423400A
(zh)
|
2018-12-11 |
2021-09-21 |
小蜜橘制药公司 |
用于治疗或预防头痛的组合物、装置和方法
|
WO2022132018A1
(en)
*
|
2020-12-16 |
2022-06-23 |
Liw Innovation Ab |
A new powder composition
|
WO2023192691A2
(en)
*
|
2022-04-01 |
2023-10-05 |
Wake Forest University Health Sciences |
Methods and formulations for intranasal delivery of insulin in the treatment of diabetic eye disease
|